Message #22 From:
NewsBot Date: October 31, 2006 05:00:00 AM
AVAN News AVANT To Present At Rodman & Renshaw 8th Annual Healthcare Conference
NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Dr.
Una S. Ryan, President and Chief Executive Officer of AVANT
Immunotherapeutics, Inc., will present at the Rodman & Renshaw 8th
Annual Healthcare Conference on Tuesday, November 7th
at 3:10 p.m., ET. The conference is being held November 6-8, 2006 in New
York City at the New York Palace Hotel.
A live audio webcast of the presentation will be available online via
the Investor Information area of AVANT’s web
site at http://www.avantimmune.com
or via the conference-sponsored website at http://www.wsw.com/webcast/rrshq10/avan/.
An archive of the webcast will be available on both sites for 90 days
following the event. A conference agenda is posted on the Rodman &
Renshaw web site at www.rodmanandrenshaw.com.
AVANT Immunotherapeutics, Inc. discovers and develops innovative
vaccines and therapeutics that harness the human immune system to
prevent and treat disease. AVANT has three products on the market and
five of AVANT’s products are in clinical
development, including a treatment to reduce complement-mediated tissue
damage associated with cardiac bypass surgery and a novel vaccine for
cholesterol management. AVANT is also developing a pipeline of
bacteria-fighting products for biodefense, travelers’
vaccines, and global health needs based on AVANT’S
rapid-protecting, single-dose, oral and temperature stable vaccine
technology.
Additional information on AVANT Immunotherapeutics, Inc. can be obtained
through our site on the World Wide Web: http://www.avantimmune.com.
